Executive Summary
The July 20, 2026 insider trading pulse reveals a market characterized by cautious insider selling at elevated levels, particularly within the biotech and tech sectors, while notable insider buying is concentrated in small-cap and distressed names, signaling potential value opportunities.
A significant cluster of 10b5-1 plan sales from multiple C-suite executives at Sea Ltd, MapLight Therapeutics, and Nexxen International suggests pre-planned, tax-related, or liquidity-driven selling rather than outright bearish sentiment, though the volume warrants monitoring. Conversely, a strong bullish signal emerges from Flora Growth Corp., where the Executive Chairman deployed $3.48M in a massive open-market purchase, and from a director at abrdn Healthcare funds who made coordinated, equal-value purchases across four closed-end funds, indicating a targeted value play. The day is dominated by neutral, non-discretionary events such as equity awards and tax-withholding sales, which do not reflect management conviction. Key themes include a concentration of insider selling in biotech (Incyte, MoonLake, MapLight), a pattern of insider buying in deeply undervalued small-caps (Flora Growth, 17 Education, SOLAI), and a notable lack of forward-looking guidance or capital allocation changes in the filings, limiting catalyst visibility. The most actionable intelligence lies in the contrast between the high-conviction buying in select micro-caps and the systematic, 10b5-1-driven selling in growth and biotech names, suggesting a rotation from momentum to deep value.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Tracking the trend? Catch up on the prior USA Insider Trading Pulse digest from July 17, 2026.
Investment Signals (12)
- Flora Growth Corp. ↓ (BULLISH)▲
Executive Chairman Heinrich Michael made a massive open-market purchase of 4.6M shares for $3.48M at $0.75, increasing his stake from zero to a significant position, signaling extreme confidence in a turnaround or undervaluation.
- Sea Ltd ↓ (BEARISH)▲
CFO Hou Tianyu sold $609K, COO Ye Gang sold $620K, and CCO Wang Yanjun sold $50.7K, all under 10b5-1 plans, representing a coordinated senior management sell-off totaling ~$1.28M, which may signal a perceived peak or need for liquidity despite the stock trading near $103-108.
- MapLight Therapeutics, Inc. ↓ (BEARISH)▲
CAO/Interim CFO Jonathan Gillis sold $638K and Chief Discovery Officer Anatol Kreitzer sold $533K, both under 10b5-1 plans, representing significant insider cash-outs at ~$37/share, potentially indicating a belief the stock is fairly valued or a need for diversification.
- abrdn Healthcare Funds (4 filings) (BULLISH)▲
Director Chris LaVictoire Mahai made coordinated purchases of exactly $10.5K each in four different closed-end funds (HQH, HQL, HIO, THW) at prices ranging from $13.20 to $20.96, signaling a targeted value play on the healthcare CEF sector.
- 17 Education & Technology Group Inc. ↓ (BULLISH)▲
CEO Liu Chang made multiple open-market purchases totaling $15.9K at an average price of ~$2.08, increasing his stake, signaling confidence in the company's turnaround or undervaluation despite its small market cap.
- SOLAI Ltd ↓ (BULLISH)▲
Director Law Man San bought 54,275 ADS for $194K at $3.57, a significant open-market purchase increasing his stake, signaling strong insider conviction in the company's prospects.
- Nexxen International Ltd. ↓ (BEARISH)▲
CFO Niri Sagi sold 35,000 shares for $361K at $10.31 under a 10b5-1 plan, a material sale representing ~20% of his post-transaction holdings, which could signal a lack of near-term upside conviction.
- CINTAS CORP ↓ (BEARISH)▲
Director Melanie W. Barstad sold 9,142 shares for $1.86M at $202.94 after exercising options at $27.10, a large profit-taking sale that may indicate the director believes the stock is near a peak.
- TOYOTA MOTOR CORP ↓ (BEARISH)▲
Vice Chairman Koji Sato sold 88,600 shares for $1.58M at $17.83, a significant sale by a top executive, potentially signaling a lack of confidence in the stock's near-term trajectory.
-
EVP Mohamed Khairie Issa sold 1,093 shares for $126K at $115.01 under a 10b5-1 plan, while the CEO and other executives received large equity awards, creating a mixed signal where selling is pre-planned but long-term incentives remain strong. [NEUTRAL/BEARISH]
- Freightos Ltd ↓ (BEARISH)▲
CTO Enric Alventosa Abril sold 1,353 shares for $1.73K and VP HR Andrea Indave Sesma sold 3,795 shares for $4.9K, both at ~$1.28, indicating insider pessimism in a struggling logistics tech company.
-
10% owner Mario Gabelli exercised warrants to acquire 621,928 shares for $4.29M at $6.90, a large conversion that increases his stake but does not represent new cash deployment, signaling a neutral-to-bullish long-term view. [NEUTRAL/BULLISH]
Risk Flags (10)
- Sea Ltd / Concentrated Insider Selling↓ [HIGH RISK]▼
Three senior executives (CFO, COO, CCO) sold a combined ~$1.28M in stock on the same day under 10b5-1 plans, representing a coordinated reduction in exposure that could precede a negative catalyst or sector rotation.
- MapLight Therapeutics / Dual Insider Cash-Out↓ [HIGH RISK]▼
The CAO/Interim CFO and Chief Discovery Officer sold a combined ~$1.17M in stock at ~$37/share under 10b5-1 plans, representing a significant portion of their holdings, which may indicate a lack of confidence in near-term share price appreciation.
- MoonLake Immunotherapeutics / CSO Sale↓ [MEDIUM RISK]▼
Chief Scientific Officer Kristian Reich sold 16,105 shares for $322K at $20.01 under a 10b5-1 plan, a sale by a key scientific leader that could signal concerns about pipeline progress or valuation.
- Nexxen International / CFO Sells 20% of Holdings↓ [MEDIUM RISK]▼
CFO Sagi Niri sold 35,000 shares for $361K, representing ~20% of his post-transaction holdings, a material reduction that warrants monitoring for further selling.
- CINTAS CORP / Director Profit-Taking↓ [MEDIUM RISK]▼
Director Barstad sold $1.86M in stock after exercising options at $27.10, a large insider sale near the stock's high that could indicate a belief the stock is fully valued.
- TOYOTA Motor / Vice Chairman Sale↓ [MEDIUM RISK]▼
Vice Chairman Sato sold $1.58M in stock, a rare and significant sale by a top executive that may signal concerns about the company's EV strategy or macro headwinds.
- Freightos Ltd / Insider Exodus↓ [HIGH RISK]▼
Both the CTO and VP of HR sold shares at ~$1.28, indicating a lack of confidence in the company's turnaround prospects, especially given the low stock price.
- INCYTE Corp / Mixed Insider Signals↓ [MEDIUM RISK]▼
While the CEO and other executives received large equity awards, EVP Issa sold shares under a 10b5-1 plan, creating uncertainty about management's true conviction.
- ▼
CEO Tick Lyle had 542 shares withheld for taxes at $43.04, a routine but notable event that does not signal bearishness but highlights the lack of bullish insider activity.
- ▼
Executive Chair Alan McKim had 1,265 shares withheld for taxes at $310.58, a routine transaction but notable given the high stock price, indicating no new buying.
Opportunities (10)
- Flora Growth Corp. / Deep Value Insider Buy↓ (OPPORTUNITY)◆
Executive Chairman Heinrich Michael's $3.48M open-market purchase at $0.75 represents a massive vote of confidence in a micro-cap cannabis company. With no prior holdings, this signals a potential turnaround or undervaluation.
- abrdn Healthcare CEFs / Director Value Play (OPPORTUNITY)◆
Director Chris LaVictoire Mahai made coordinated $10.5K purchases across four closed-end funds (HQH, HQL, HIO, THW) at discounts to NAV, signaling a targeted value play on healthcare assets trading at depressed prices.
- 17 Education & Technology Group / CEO Accumulation↓ (OPPORTUNITY)◆
CEO Liu Chang's multiple open-market purchases totaling $15.9K at ~$2.08 signal insider confidence in a beaten-down EdTech stock, potentially indicating a turnaround or value realization.
- SOLAI Ltd / Director Stake Increase↓ (OPPORTUNITY)◆
Director Law Man San's $194K purchase at $3.57 increases his stake significantly, signaling confidence in a solar energy company that may be undervalued relative to its growth prospects.
- LGL GROUP INC / Mario Gabelli Warrant Exercise↓ (OPPORTUNITY)◆
10% owner Mario Gabelli exercised warrants to acquire 621,928 shares at $6.90, a large conversion that increases his stake and signals long-term conviction in the company's value.
- INCYTE Corp / CEO Equity Award as Alignment Signal↓ (OPPORTUNITY)◆
CEO William Meury received 26,807 shares, 80,421 performance shares, and 77,148 options, a massive long-term incentive package that aligns management with shareholders and signals confidence in the pipeline.
- Texas Pacific Land Corp / 10% Owner Token Buy↓ (OPPORTUNITY)◆
Horizon Kinetics bought 1 share at $420.15, a symbolic purchase that, while immaterial in size, signals continued confidence from a major institutional holder in a high-quality asset.
- RENN Fund, Inc. / 10% Owner Accumulation↓ (OPPORTUNITY)◆
Horizon Kinetics bought 756 shares at $3.02, a small but consistent purchase that signals continued support from a major shareholder in a closed-end fund trading at a discount.
- MultiSensor AI Holdings / CEO and CFO Equity Awards↓ (OPPORTUNITY)◆
CEO Asim Akram and CFO Robert Nadolny received 20,841 and 17,935 shares respectively, aligning their interests with shareholders in an AI-focused company, though no cash was deployed.
- CULP INC / Insider Option Exercises↓ (OPPORTUNITY)◆
Chief Commercial Officer Bruno Thomas and SVP Teresa Huffman exercised and converted RSUs into common stock, indicating they are willing to hold equity rather than cash out, a mildly bullish signal for a small-cap textile company.
Sector Themes (6)
- Biotech Insider Selling Dominates (CAUTION)◆
Three biotech companies (MoonLake, MapLight, Incyte) saw insider sales totaling ~$1.62M, all under 10b5-1 plans, suggesting a sector-wide trend of executives taking profits or diversifying, potentially ahead of clinical data readouts or regulatory decisions.
- Tech Insider Selling at Sea Ltd (CAUTION)◆
Sea Ltd saw a coordinated sell-off by three C-suite executives totaling ~$1.28M, a pattern that may indicate a sector rotation out of high-growth tech names or a belief that the stock is fully valued.
- Small-Cap Value Insider Buying (OPPORTUNITY)◆
A cluster of insider buying in micro-cap and small-cap stocks (Flora Growth, 17 Education, SOLAI, abrdn CEFs) suggests a rotation into deep value, where insiders see significant upside potential.
- Closed-End Fund Director Value Play (OPPORTUNITY)◆
Director Mahai's coordinated purchases across four abrdn healthcare CEFs at equal dollar amounts ($10.5K each) signals a targeted strategy to buy discounted assets in the healthcare sector, potentially ahead of a sector rotation.
- Equity Awards as Primary Insider Activity (NEUTRAL)◆
The majority of filings (30+) involve non-discretionary equity awards, RSUs, or tax-withholding sales, indicating that most insiders are not actively trading on conviction, reducing the signal-to-noise ratio.
- 10b5-1 Plan Sales Dominate Discretionary Selling (NEUTRAL)◆
All significant insider sales (Sea Ltd, MapLight, MoonLake, Nexxen, Incyte, CINTAS) were executed under 10b5-1 plans, making them less actionable as bearish signals but still worth monitoring for pattern changes.
Watch List (8)
- 👁
Monitor for any acceleration of insider sales beyond the 10b5-1 plan or any insider buying, which would be a strong reversal signal. Next earnings call expected in August 2026.
- 👁
Watch for any additional open-market purchases by Chairman Heinrich Michael, which would further validate the bullish thesis. The company's next quarterly report will be key to assess fundamentals.
- 👁
Monitor for any insider buying after the 10b5-1 plan sales, which would signal a reversal. The company's clinical trial updates will be a key catalyst.
- 👁
The large equity awards to the CEO and other executives will vest over time; monitor for any insider sales upon vesting, which could signal a lack of long-term confidence.
- abrdn Healthcare CEFs / Director Purchases (WATCH)👁
Monitor for any additional purchases by Director Mahai or other insiders, which would confirm the value thesis. The funds' NAV discounts are key metrics to track.
- CINTAS Corp / Director Selling↓ (WATCH)👁
Watch for any additional sales by Director Barstad or other insiders, which could indicate a broader trend of insider profit-taking at the stock's highs.
-
Monitor for any further sales by Vice Chairman Sato or other top executives, which could signal deeper concerns about the company's strategy.
-
Watch for continued open-market purchases by CEO Liu Chang, which would strengthen the bullish signal. The company's next earnings report will be critical.
Filing Analyses
(50)
20-07-2026
Executive Chairman Heinrich Michael bought 4,608,575 Common Shares at $0.75 (~$3.48M). Heinrich Michael holds 4,608,575 shares after the transaction.
- · Executive Chairman Heinrich Michael bought 4,608,575 Common Shares at $0.75 (~$3.48M)
- · Executive Chairman Heinrich Michael was awarded 500,000 Employee Stock Option (Right to Buy)
20-07-2026
Director ZANELLA STEVEN J was awarded 120,000 Class A Common Stock. ZANELLA STEVEN J holds 364,992 shares after the transaction.
- · Director ZANELLA STEVEN J was awarded 120,000 Class A Common Stock
20-07-2026
Director Horowitz Hyman Joseph was awarded 120,000 Class A Common Stock. Horowitz Hyman Joseph holds 364,992 shares after the transaction.
- · Director Horowitz Hyman Joseph was awarded 120,000 Class A Common Stock
20-07-2026
Director MENCHER JUDY K was awarded 120,000 Class A Common Stock. MENCHER JUDY K holds 364,992 shares after the transaction.
- · Director MENCHER JUDY K was awarded 120,000 Class A Common Stock
20-07-2026
Director Von Furstenberg Alexander was awarded 5,490 Restricted Stock Units.
- · Director Von Furstenberg Alexander was awarded 5,490 Restricted Stock Units
20-07-2026
Director Hargroves Thomas Jeffrey was awarded 20,000 Stock Option (right to Buy).
- · Director Hargroves Thomas Jeffrey was awarded 20,000 Stock Option (right to Buy)
20-07-2026
Director Law Man San bought 54,275 American Depositary Shares at $3.57 (~$194K). Law Man San holds 132,242 shares after the transaction.
- · Director Law Man San bought 54,275 American Depositary Shares at $3.57 (~$194K)
20-07-2026
Chief Scientific Officer Reich Kristian sold 16,105 Class A ordinary shares, par value $0.0001 per share at $20.01 (~$322K). Reich Kristian holds 2,808,446 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Scientific Officer Reich Kristian sold 16,105 Class A ordinary shares, par value $0.0001 per share at $20.01 (~$322K)
20-07-2026
CFO Hou Tianyu sold 5,887 Class A ordinary shares at $103.51 (~$609K). 5 transactions reported in total. Hou Tianyu holds 960 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CFO Hou Tianyu sold 2,840 Class A ordinary shares at $101.48 (~$288K)
- · CFO Hou Tianyu sold 2,177 Class A ordinary shares at $102.54 (~$223K)
- · CFO Hou Tianyu sold 5,887 Class A ordinary shares at $103.51 (~$609K)
- · CFO Hou Tianyu sold 3,136 Class A ordinary shares at $104.35 (~$327K)
- · CFO Hou Tianyu sold 960 Class A ordinary shares at $105.11 (~$101K)
20-07-2026
CAO and Interim CFO GILLIS JONATHAN sold 16,969 Voting Common Stock at $37.61 (~$638K). 7 transactions reported in total. GILLIS JONATHAN holds 144,240 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CAO and Interim CFO GILLIS JONATHAN sold 5,356 Voting Common Stock at $36.13 (~$194K)
- · CAO and Interim CFO GILLIS JONATHAN sold 4,699 Voting Common Stock at $36.94 (~$174K)
- · CAO and Interim CFO GILLIS JONATHAN sold 6,979 Voting Common Stock at $36.66 (~$256K)
- · CAO and Interim CFO GILLIS JONATHAN sold 1,476 Voting Common Stock at $37.44 (~$55.3K)
- · CAO and Interim CFO GILLIS JONATHAN sold 600 Voting Common Stock at $36.51 (~$21.9K)
- · CAO and Interim CFO GILLIS JONATHAN sold 16,969 Voting Common Stock at $37.61 (~$638K)
- · CAO and Interim CFO GILLIS JONATHAN sold 900 Voting Common Stock at $38.17 (~$34.4K)
20-07-2026
Chief Financial Officer Niri Sagi sold 35,000 Common Stock at $10.31 (~$361K). Niri Sagi holds 144,066 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Financial Officer Niri Sagi sold 35,000 Common Stock at $10.31 (~$361K)
20-07-2026
CCO and GC Wang Yanjun sold 490 Class A ordinary shares at $103.44 (~$50.7K). 11 transactions reported in total. Wang Yanjun holds 31,300 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CCO and GC Wang Yanjun sold 463 Class A ordinary shares at $106.05 (~$49.1K)
- · CCO and GC Wang Yanjun sold 211 Class A ordinary shares at $107.35 (~$22.7K)
- · CCO and GC Wang Yanjun sold 147 Class A ordinary shares at $107.96 (~$15.9K)
- · CCO and GC Wang Yanjun sold 184 Class A ordinary shares at $109.10 (~$20.1K)
- · CCO and GC Wang Yanjun sold 153 Class A ordinary shares at $110.12 (~$16.8K)
- · CCO and GC Wang Yanjun sold 342 Class A ordinary shares at $111.00 (~$38K)
- · CCO and GC Wang Yanjun sold 223 Class A ordinary shares at $101.46 (~$22.6K)
- · CCO and GC Wang Yanjun sold 205 Class A ordinary shares at $102.47 (~$21K)
20-07-2026
COO Ye Gang sold 5,778 Class A ordinary shares at $107.29 (~$620K). 11 transactions reported in total. Ye Gang holds 320,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · COO Ye Gang sold 4,199 Class A ordinary shares at $106.28 (~$446K)
- · COO Ye Gang sold 5,778 Class A ordinary shares at $107.29 (~$620K)
- · COO Ye Gang sold 2,877 Class A ordinary shares at $108.01 (~$311K)
- · COO Ye Gang sold 3,611 Class A ordinary shares at $109.15 (~$394K)
- · COO Ye Gang sold 2,639 Class A ordinary shares at $110.14 (~$291K)
- · COO Ye Gang sold 896 Class A ordinary shares at $110.95 (~$99.4K)
- · COO Ye Gang sold 3,932 Class A ordinary shares at $101.44 (~$399K)
- · COO Ye Gang sold 4,519 Class A ordinary shares at $102.40 (~$463K)
20-07-2026
Chief Discovery Officer Kreitzer Anatol sold 14,140 Voting Common Stock at $37.70 (~$533K). 7 transactions reported in total. Kreitzer Anatol holds 174,906 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Discovery Officer Kreitzer Anatol sold 5,545 Voting Common Stock at $36.13 (~$200K)
- · Chief Discovery Officer Kreitzer Anatol sold 4,510 Voting Common Stock at $36.94 (~$167K)
- · Chief Discovery Officer Kreitzer Anatol sold 7,464 Voting Common Stock at $36.66 (~$274K)
- · Chief Discovery Officer Kreitzer Anatol sold 1,592 Voting Common Stock at $37.44 (~$59.6K)
- · Chief Discovery Officer Kreitzer Anatol sold 2,833 Voting Common Stock at $37.05 (~$105K)
- · Chief Discovery Officer Kreitzer Anatol sold 14,140 Voting Common Stock at $37.70 (~$533K)
- · Chief Discovery Officer Kreitzer Anatol sold 200 Voting Common Stock at $38.39 (~$7.68K)
20-07-2026
Director Hee Theng Fong exercised/converted 31,640 Ordinary Shares. Hee Theng Fong holds 31,640 shares after the transaction.
- · Director Hee Theng Fong exercised/converted 31,640 Ordinary Shares
- · Director Hee Theng Fong exercised/converted 31,640 Restricted Share Units
20-07-2026
Chief Executive Officer Liu Chang bought 7,633 American depositary shares at $2.08 (~$15.9K). 5 transactions reported in total. Liu Chang holds 34,927 shares after the transaction.
- · Chief Executive Officer Liu Chang acquired 874 American depositary shares at $2.33 (~$2.03K)
- · Chief Executive Officer Liu Chang acquired 499 American depositary shares at $2.48 (~$1.24K)
- · Chief Executive Officer Liu Chang acquired 2,703 American depositary shares at $2.13 (~$5.75K)
- · Chief Executive Officer Liu Chang acquired 308 American depositary shares at $2.17 (~$667)
- · Chief Executive Officer Liu Chang bought 7,633 American depositary shares at $2.08 (~$15.9K)
20-07-2026
CEO & President Tick Lyle had withheld for taxes 542 Common Stock at $43.04 (~$23.3K). Tick Lyle holds 32,330 shares after the transaction.
- · CEO & President Tick Lyle had withheld for taxes 542 Common Stock at $43.04 (~$23.3K)
20-07-2026
Director Hureau Robert Paul was awarded 1,133 Restricted Stock Unit.
- · Director Hureau Robert Paul was awarded 1,133 Restricted Stock Unit
20-07-2026
Director Nearhos Barry R was awarded 170 Common Stock. Nearhos Barry R holds 31,494 shares after the transaction.
- · Director Nearhos Barry R was awarded 170 Common Stock
20-07-2026
Vice Chairman Sato Koji sold 88,600 Common Stock at $17.83 (~$1.58M). Sato Koji holds 567,600 shares after the transaction.
- · Vice Chairman Sato Koji sold 88,600 Common Stock at $17.83 (~$1.58M)
20-07-2026
Chief Executive Officer Hill Alan Finbar acquired 100,000 Class B Ordinary Shares at $0.00 (~$300).
- · Chief Executive Officer Hill Alan Finbar acquired 100,000 Class B Ordinary Shares at $0.00 (~$300)
20-07-2026
Director Campbell Kristina Stanier was awarded 83,026 Warrant for Common Stock. 4 transactions reported in total.
- · Director Campbell Kristina Stanier was awarded 83,026 Warrant for Common Stock
- · Director Campbell Kristina Stanier was awarded 41,513 Warrant for Common Stock
- · Director Campbell Kristina Stanier was awarded 41,513 Warrant for Common Stock
- · Director Campbell Kristina Stanier was awarded 41,513 Warrant for Common Stock
20-07-2026
Chief Accounting Officer Sitaram Siddharth sold 1,732 Class A Common Stock at $22.02 (~$38.1K). 5 transactions reported in total. Sitaram Siddharth holds 93,774 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Accounting Officer Sitaram Siddharth exercised/converted 4,800 Class A Common Stock
- · Chief Accounting Officer Sitaram Siddharth sold 1,732 Class A Common Stock at $22.02 (~$38.1K)
- · Chief Accounting Officer Sitaram Siddharth exercised/converted 4,800 Stock Option (Right to Buy)
- · Chief Accounting Officer Sitaram Siddharth exercised/converted 4,800 Class B Common Stock
- · Chief Accounting Officer Sitaram Siddharth exercised/converted 4,800 Class B Common Stock
20-07-2026
10% owner HORIZON KINETICS ASSET MANAGEMENT LLC bought 1 Common Stock at $420.15 (~$420). HORIZON KINETICS ASSET MANAGEMENT LLC holds 3,263,678 shares after the transaction.
- · 10% owner HORIZON KINETICS ASSET MANAGEMENT LLC bought 1 Common Stock at $420.15 (~$420)
20-07-2026
EXEC CHAIR, CTO. MCKIM ALAN S had withheld for taxes 1,265 Common Stock at $310.58 (~$393K). MCKIM ALAN S holds 30,154 shares after the transaction.
- · EXEC CHAIR, CTO. MCKIM ALAN S had withheld for taxes 1,265 Common Stock at $310.58 (~$393K)
20-07-2026
10% owner HORIZON KINETICS ASSET MANAGEMENT LLC bought 756 Common Stock at $3.02 (~$2.28K). HORIZON KINETICS ASSET MANAGEMENT LLC holds 937,200 shares after the transaction.
- · 10% owner HORIZON KINETICS ASSET MANAGEMENT LLC bought 756 Common Stock at $3.02 (~$2.28K)
20-07-2026
Chief Commercial Officer Bruno Thomas had withheld for taxes 5,088 Common Stock at $3.70 (~$18.8K). Bruno Thomas holds 102,819 shares after the transaction.
- · Chief Commercial Officer Bruno Thomas exercised/converted 17,907 Common Stock
- · Chief Commercial Officer Bruno Thomas had withheld for taxes 5,088 Common Stock at $3.70 (~$18.8K)
- · Chief Commercial Officer Bruno Thomas exercised/converted 17,907 Restricted Stock Units
20-07-2026
SVP & CHRO Huffman Teresa Atkins had withheld for taxes 2,952 Common Stock at $3.70 (~$10.9K). Huffman Teresa Atkins holds 16,043 shares after the transaction.
- · SVP & CHRO Huffman Teresa Atkins exercised/converted 8,749 Common Stock
- · SVP & CHRO Huffman Teresa Atkins had withheld for taxes 2,952 Common Stock at $3.70 (~$10.9K)
- · SVP & CHRO Huffman Teresa Atkins exercised/converted 8,749 Restricted Stock Units
20-07-2026
Director Dewar Patrick M was awarded 5.9606 Restricted Share Units at $318.52 (~$1.9K).
- · Director Dewar Patrick M was awarded 5.9606 Restricted Share Units at $318.52 (~$1.9K)
20-07-2026
Director Hess Janice L. was awarded 0.2478 Restricted Share Units at $318.52 (~$78.9).
- · Director Hess Janice L. was awarded 0.2478 Restricted Share Units at $318.52 (~$78.9)
20-07-2026
Director Mahai Chris LaVictoire bought 501 Common Stock at $20.96 (~$10.5K). Mahai Chris LaVictoire holds 501 shares after the transaction.
- · Director Mahai Chris LaVictoire bought 501 Common Stock at $20.96 (~$10.5K)
20-07-2026
Director Campbell David A was awarded 0.9117 Restricted Share Units at $318.52 (~$290).
- · Director Campbell David A was awarded 0.9117 Restricted Share Units at $318.52 (~$290)
20-07-2026
Director Mahai Chris LaVictoire bought 527 Common Stock at $19.92 (~$10.5K). Mahai Chris LaVictoire holds 527 shares after the transaction.
- · Director Mahai Chris LaVictoire bought 527 Common Stock at $19.92 (~$10.5K)
20-07-2026
Director PHILLIPPY ROBERT J was awarded 4.9827 Restricted Share Units at $318.52 (~$1.59K).
- · Director PHILLIPPY ROBERT J was awarded 4.9827 Restricted Share Units at $318.52 (~$1.59K)
20-07-2026
Director Conner Penelope M was awarded 0.194 Restricted Share Units at $318.52 (~$61.8).
- · Director Conner Penelope M was awarded 0.194 Restricted Share Units at $318.52 (~$61.8)
20-07-2026
Director Mahai Chris LaVictoire bought 568 Common Stock at $18.49 (~$10.5K). Mahai Chris LaVictoire holds 568 shares after the transaction.
- · Director Mahai Chris LaVictoire bought 568 Common Stock at $18.49 (~$10.5K)
20-07-2026
Director Mahai Chris LaVictoire bought 796 Common Stock at $13.20 (~$10.5K). Mahai Chris LaVictoire holds 796 shares after the transaction.
- · Director Mahai Chris LaVictoire bought 796 Common Stock at $13.20 (~$10.5K)
20-07-2026
Chief Executive Officer Meury William was awarded 26,807 Common Stock. Meury William holds 183,129 shares after the transaction.
- · Chief Executive Officer Meury William was awarded 26,807 Common Stock
- · Chief Executive Officer Meury William was awarded 80,421 Performance Shares
- · Chief Executive Officer Meury William was awarded 77,148 Employee Stock Option (right to buy)
20-07-2026
Chief Executive Officer Akram Asim was awarded 20,841 Common Stock. Akram Asim holds 25,201 shares after the transaction.
- · Chief Executive Officer Akram Asim was awarded 20,841 Common Stock
20-07-2026
President, Global Head of R&D CAGNONI PABLO J was awarded 13,403 Common Stock. CAGNONI PABLO J holds 231,332 shares after the transaction.
- · President, Global Head of R&D CAGNONI PABLO J was awarded 13,403 Common Stock
- · President, Global Head of R&D CAGNONI PABLO J was awarded 33,508 Performance Shares
- · President, Global Head of R&D CAGNONI PABLO J was awarded 57,861 Employee Stock Option (right to buy)
20-07-2026
EVP, Head of U.S. Commercial Issa Mohamed Khairie sold 1,093 Common Stock at $115.01 (~$126K). 4 transactions reported in total. Issa Mohamed Khairie holds 71,797 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · EVP, Head of U.S. Commercial Issa Mohamed Khairie sold 1,093 Common Stock at $115.01 (~$126K)
- · EVP, Head of U.S. Commercial Issa Mohamed Khairie was awarded 7,857 Common Stock
- · EVP, Head of U.S. Commercial Issa Mohamed Khairie was awarded 19,643 Performance Shares
- · EVP, Head of U.S. Commercial Issa Mohamed Khairie was awarded 33,918 Employee Stock Option (right to buy)
20-07-2026
Chief Technology Officer Alventosa Abril Enric sold 1,353 Ordinary Shares at $1.28 (~$1.73K). Alventosa Abril Enric holds 16,774 shares after the transaction.
- · Chief Technology Officer Alventosa Abril Enric sold 1,175 Ordinary Shares at $1.28 (~$1.5K)
- · Chief Technology Officer Alventosa Abril Enric sold 1,353 Ordinary Shares at $1.28 (~$1.73K)
20-07-2026
EVP & General Counsel Hoffman Richard A. was awarded 7,395 Common Stock. Hoffman Richard A. holds 16,861 shares after the transaction.
- · EVP & General Counsel Hoffman Richard A. was awarded 7,395 Common Stock
- · EVP & General Counsel Hoffman Richard A. was awarded 18,487 Performance Shares
- · EVP & General Counsel Hoffman Richard A. was awarded 31,923 Employee Stock Option (right to buy)
20-07-2026
EVP, Human Resources Basi Ramitpal K was awarded 4,991 Common Stock. Basi Ramitpal K holds 11,497 shares after the transaction.
- · EVP, Human Resources Basi Ramitpal K was awarded 4,991 Common Stock
- · EVP, Human Resources Basi Ramitpal K was awarded 12,479 Performance Shares
- · EVP, Human Resources Basi Ramitpal K was awarded 21,548 Employee Stock Option (right to buy)
20-07-2026
EVP, Chief Strategy Officer Gardner David H was awarded 7,395 Common Stock. Gardner David H holds 16,824 shares after the transaction.
- · EVP, Chief Strategy Officer Gardner David H was awarded 7,395 Common Stock
- · EVP, Chief Strategy Officer Gardner David H was awarded 18,487 Performance Shares
- · EVP, Chief Strategy Officer Gardner David H was awarded 31,923 Employee Stock Option (right to buy)
20-07-2026
10% owner GABELLI MARIO J exercised/converted 621,928 Common Stock at $6.90 (~$4.29M). 4 transactions reported in total. GABELLI MARIO J holds 1,144,648 shares after the transaction.
- · 10% owner GABELLI MARIO J exercised/converted 621,928 Common Stock at $6.90 (~$4.29M)
- · 10% owner GABELLI MARIO J exercised/converted 572,324 Common Stock at $6.90 (~$3.95M)
- · 10% owner GABELLI MARIO J exercised/converted 621,928 Subscription Rights (right to purchase)
- · 10% owner GABELLI MARIO J exercised/converted 572,324 Subscription Rights (right to purchase)
20-07-2026
Chief Financial Officer Nadolny Robert was awarded 17,935 Common Stock. Nadolny Robert holds 23,491 shares after the transaction.
- · Chief Financial Officer Nadolny Robert was awarded 17,935 Common Stock
20-07-2026
VP, Human Resources Indave Sesma Andrea sold 3,795 Ordinary Shares at $1.29 (~$4.9K). Indave Sesma Andrea holds 24,205 shares after the transaction.
- · VP, Human Resources Indave Sesma Andrea sold 199 Ordinary Shares at $1.27 (~$253)
- · VP, Human Resources Indave Sesma Andrea sold 672 Ordinary Shares at $1.28 (~$860)
- · VP, Human Resources Indave Sesma Andrea sold 3,795 Ordinary Shares at $1.29 (~$4.9K)
20-07-2026
Director Barstad Melanie W. sold 9,142 Common Stock at $202.94 (~$1.86M). 4 transactions reported in total. Barstad Melanie W. holds 26,592 shares after the transaction.
- · Director Barstad Melanie W. exercised/converted 10,548 Common Stock at $27.10 (~$286K)
- · Director Barstad Melanie W. had withheld for taxes 1,406 Common Stock at $203.44 (~$286K)
- · Director Barstad Melanie W. sold 9,142 Common Stock at $202.94 (~$1.86M)
- · Director Barstad Melanie W. exercised/converted 10,548 Stock Option (right to buy)
20-07-2026
Director DUBIN THOMAS I H was awarded 5,500 Stock Option (right to buy Common Stock).
- · Director DUBIN THOMAS I H was awarded 5,500 Stock Option (right to buy Common Stock)
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: USA Insider Trading Pulse
🇺🇸 More from United States
View all →July 22, 2026
US Pre-Market SEC Filings Roundup — July 22, 2026
US Pre-Market SEC Filings Roundup
July 21, 2026
US Pre-Market SEC Filings Roundup — July 21, 2026
US Pre-Market SEC Filings Roundup
July 21, 2026
S&P 500 Technology Sector SEC Filings — July 21, 2026
S&P 500 Technology Sector SEC Filings
July 21, 2026
US Merger & Acquisition SEC Filings — July 21, 2026
US Merger & Acquisition SEC Filings